http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1171101-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac2c17e532220d91aca9a28ef60f178b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1694
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-26
filingDate 2000-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2007-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e00a12345d46d4a374fcd1e6670ca451
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c2017f88d103bb5074c2b0b4c50293d
publicationDate 2007-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1171101-B1
titleOfInvention Method for producing a water-insoluble amorphous controlled release matrix
abstract In the preparation of a medicament dosage form (or its precursor) by extrusion, the dosage form comprises a matrix having properties determined by the extrusion process. The matrix contains (a) at least one active agent, (b) one or more polysaccharides (and their derivatives and complexes) and, optionally, (c) one or more saccharides (and their derivatives) and (d) other materials. An independent claim is included for the dosage forms as described above.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102011011889-A1
priorityDate 1999-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0029477-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9902600-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265

Total number of triples: 34.